Hologic Inc. (HOLX)
NASDAQ: HOLX
· Real-Time Price · USD
62.16
-0.76 (-1.21%)
At close: May 30, 2025, 3:59 PM
61.33
-1.34%
After-hours: May 30, 2025, 05:31 PM EDT
Hologic Revenue Breakdown
| Period Ending | Sep 28, 2024 | Sep 24, 2022 | Sep 25, 2021 | Sep 26, 2020 | Sep 29, 2018 | Sep 30, 2017 | Sep 24, 2016 | Sep 26, 2015 | Sep 27, 2014 | Sep 28, 2013 | Sep 29, 2012 | Sep 24, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast Health Revenue | 1.52B | 1.23B | 1.35B | 1.15B | 1.22B | 1.14B | 1.11B | 1.06B | 944.7M | 905.08M | 875.77M | 825.55M |
| Breast Health Revenue Growth | +24.03% | -9.21% | +17.40% | -5.44% | +7.02% | +2.29% | +4.65% | +12.56% | +4.38% | +3.35% | +6.08% | n/a |
| Diagnostics Revenue | 1.78B | 3.02B | 3.69B | 2.1B | 1.15B | 1.2B | 1.24B | 1.21B | 1.19B | 1.19B | 718.06M | 571.26M |
| Diagnostics Revenue Growth | -40.96% | -18.31% | +75.78% | +83.21% | -4.15% | -3.22% | +2.07% | +2.11% | -0.25% | +65.70% | +25.70% | n/a |
| Gyn Surgical Revenue | 641.3M | 522.9M | 488.1M | 376.1M | 422M | 427.1M | 393.1M | 335.8M | 307.9M | 307.14M | 313.09M | 300.54M |
| Gyn Surgical Revenue Growth | +22.64% | +7.13% | +29.78% | -10.88% | -1.19% | +8.65% | +17.06% | +9.06% | +0.25% | -1.90% | +4.18% | n/a |
| Skeletal Health Revenue | 84.1M | 93.6M | 96.9M | 81M | 91.2M | 88.8M | 89.9M | 94M | 91.3M | 90.25M | 95.73M | 92M |
| Skeletal Health Revenue Growth | -10.15% | -3.41% | +19.63% | -11.18% | +2.70% | -1.22% | -4.36% | +2.96% | +1.17% | -5.73% | +4.06% | n/a |
Revenue by Geography
| Period Ending | Sep 28, 2024 | Sep 30, 2023 | Sep 24, 2022 | Sep 25, 2021 | Sep 26, 2020 | Sep 28, 2019 |
|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 259.6M | 255.7M | 359.7M | 365M | 226.8M | 286M |
| Asia Pacific Revenue Growth | +1.53% | -28.91% | -1.45% | +60.93% | -20.70% | n/a |
| Europe Revenue | 532.7M | 520.3M | 888.5M | 1.2B | 569.8M | 396M |
| Europe Revenue Growth | +2.38% | -41.44% | -26.07% | +110.92% | +43.89% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Sep 24, 2022 | Jun 25, 2022 | Mar 26, 2022 | Dec 25, 2021 | Sep 25, 2021 | Jun 26, 2021 | Mar 27, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Sep 24, 2016 | Jun 25, 2016 | Mar 26, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 274.1M | 281.8M | 249.2M | 240.3M | 244.6M | 260.7M | 232.4M | 240M | 243.2M | 272M | 256.5M | 244.2M | 271.9M | 265.3M | 294.5M | 260M | 220.4M | 219.5M | 221.3M | 208.8M | 177.1M | 233.4M | 225.5M | 223.5M | 223.4M | 224.6M | 251.6M | 227.4M | 214.3M | 217.4M | 230.3M | 210.9M | 220.8M | 179.8M | 171.2M | 171.5M | 163.2M | 176.4M | 165.9M | 167.4M | 143.3M |
| Selling, General, and Administrative Revenue Growth | -2.73% | +13.08% | +3.70% | -1.76% | -6.18% | +12.18% | -3.17% | -1.32% | -10.59% | +6.04% | +5.04% | -10.19% | +2.49% | -9.92% | +13.27% | +17.97% | +0.41% | -0.81% | +5.99% | +17.90% | -24.12% | +3.50% | +0.89% | +0.04% | -0.53% | -10.73% | +10.64% | +6.11% | -1.43% | -5.60% | +9.20% | -4.48% | +22.80% | +5.02% | -0.17% | +5.09% | -7.48% | +6.33% | -0.90% | +16.82% | n/a |
| Research and Development Revenue | 61.5M | 60.3M | 67.3M | 64.1M | 74.6M | 66.8M | 72.9M | 72.6M | 126.1M | 74.8M | 76M | 65.1M | 69.5M | 72.8M | 76.5M | 69M | 71.5M | 59.3M | 57M | 55.1M | 49.3M | 61.2M | 60.4M | 61.4M | 57.3M | 53.2M | 52.7M | 54.4M | 56.8M | 54.8M | 60.5M | 62.5M | 55.4M | 54.4M | 62.5M | 58.8M | 59.1M | 51.7M | 53.8M | 56M | 53.3M |
| Research and Development Revenue Growth | +1.99% | -10.40% | +4.99% | -14.08% | +11.68% | -8.37% | +0.41% | -42.43% | +68.58% | -1.58% | +16.74% | -6.33% | -4.53% | -4.84% | +10.87% | -3.50% | +20.57% | +4.04% | +3.45% | +11.76% | -19.44% | +1.32% | -1.63% | +7.16% | +7.71% | +0.95% | -3.12% | -4.23% | +3.65% | -9.42% | -3.20% | +12.82% | +1.84% | -12.96% | +6.29% | -0.51% | +14.31% | -3.90% | -3.93% | +5.07% | n/a |
| Sales and Marketing Revenue | 154.4M | 166.1M | 146M | 146.3M | 144.2M | 148.9M | 139.5M | 149.8M | 142.4M | 163.5M | 159.3M | 152.3M | 171.4M | 147.4M | 159.1M | 142.7M | 131.5M | 128M | 125.7M | 103.5M | 110.6M | 144.9M | 141.8M | 143.6M | 133.5M | 146M | 133.5M | 141.1M | 130.5M | 139.5M | 139.7M | 145.4M | 103.4M | 110M | 105.8M | 109M | 100.8M | 99.4M | 99.7M | 94.3M | 83M |
| Sales and Marketing Revenue Growth | -7.04% | +13.77% | -0.21% | +1.46% | -3.16% | +6.74% | -6.88% | +5.20% | -12.91% | +2.64% | +4.60% | -11.14% | +16.28% | -7.35% | +11.49% | +8.52% | +2.73% | +1.83% | +21.45% | -6.42% | -23.67% | +2.19% | -1.25% | +7.57% | -8.56% | +9.36% | -5.39% | +8.12% | -6.45% | -0.14% | -3.92% | +40.62% | -6.00% | +3.97% | -2.94% | +8.13% | +1.41% | -0.30% | +5.73% | +13.61% | n/a |